BUSTED: Eight NIH Coronavirus Treatment Experts Disclosed Financial Ties To Gilead

The post
BUSTED: Eight NIH Coronavirus Treatment Experts Disclosed Financial
Ties To Gilead appeared first on National File. Visit
NationalFile.com for more hard-hitting investigative
journalism.

Eight members of the National Institutes of Health (NIH) expert
COVID-19 Treatment Guidelines Panel disclosed recent financial
relationships with Gilead, the drugmaker that is introducing an
expensive Coronavirus competitor to Hydroxychloroquine, the
inexpensive anti-malarial drug that President Trump has promoted
which many people claim has helped them. This financial
relationship between NIH experts and Gilead is especially
concerning in light of
revelations that NIH has a financial stake in the Bill Gates-funded
Moderna vaccine, another competitor to Hydroxychloroquine.
Chloroquine critic Dr. Anthony Fauci’s NIAID, which
funded the Bat Coronavirus research at the Wuhan Institute of
Virology believed to be the source of the outbreak, is part of
NIH.

HERE IS THE FINANCIAL DISCLOSURE LIST FOR THE NIH EXPERT
CORONAVIRUS TREATMENT PANEL. The experts with disclosed ties to
Gilead include consultants, people who provided Gilead research
support, and honoraria. Members of the panel also disclosed ties to
Merck and INOVIO Pharmaceuticals, which took $9 million from a
Gates-backed company to develop a Coronavirus vaccine.

Gilead is driving up their prices from what was previously
expected (as the company has done in the past).

Remdesivir price is out now.
As I suspected, it’s not cheap

Gilead is charging hospitals between $3,120 and $5,720 per
patient

Payment will begin in July, likely in anticipation of making a
profit in the second wave of COVID-19

Lot of money for a drug w/ no mortality benefit. https://t.co/DsPvNc4NBx

— James Todaro, MD (@JamesTodaroMD)
June 29, 2020

I previously reported for NATIONAL FILE:

The mainstream media is hyping a “study” with data culled from
Department of Veterans Affairs (VA) hospitals to justify their
attack on Hydroxychloroquine, an anti-malaria drug that President
Donald Trump is fighting to provide to suffering people. (READ:
Bon Jovi Keyboard Player Tells Us He Took Hydroxychloroquine And
Improved). ABC White House correspondent Jon Karl agitated
against Hydroxychloroquine in Trump’s Tuesday White House Task
Force briefing, citing the VA study. FDA commissioner Stephen Hahn
said “This study is a small retrospective study at the VA” and
stressed that results of clinical trials, in progress, are needed.
(READ
the Actual Study Here). The study merely polled the mostly
black elderly male Coronavirus patients who have been treated at
the VA through April 11. The study was supported by National
Institutes of Health (NIH), which
infamously funded Wuhan Institute of Virology scientists to perform
bat coronavirus research prior to the current outbreak.

The study cannot be used to credibly attack Hydroxychloroquine
because the drug was given to sicker veterans more likely to die
anyway as opposed to healthier people. The study was posted on the
Internet but not reviewed by other scientists. The study claims 22
percent of people given Hydroxychloroquine plus azithromycin died,
whereas only 11 percent died with regular care, but the study even
notes that this result was expected due to the severe pre-existing
conditions of the patients given the Trump-touted drug. The study
made no mention of VA doctors prescribing Zinc along with
Hydroxychloroquine, even though doctors and medical experts believe
that Hydroxychloroquine can only work in partnership with Zinc. One
of the authors of the study has a patent application pertaining to
Coronavirus and another author took a research grant from Gilead,
which is developing a competitor drug to Hydroxychloroquine (the
study claimed these competing interests were unrelated to the study
itself). Hydroxychloroquine costs less than $1 per tablet, whereas
Gilead was accused by a Senate Finance Committee investigation of
inflating prices to the detriment of patients. Let’s break down
why the mainstream media’s attack is flopping:

Hydroxychloroquine “was more likely to be prescribed
to patients with more severe disease”

The patients given hydroxychloroquine (ages 59 to 75) had
diseases including congestive heart failure, chronic pulmonary
disease, diabetes, liver disease, cancer and HIV/AIDS.

The study noted, “However, hydroxychloroquine, with or without
azithromycin, was more likely to be prescribed to patients with
more severe disease…Thus, as expected, increased mortality was
observed in patients treated with hydroxychloroquine both with and
without azithromycin.”

“Our study cohort comprised only men whose median age was over
65 years. Therefore, the results may not necessarily reflect
outcomes in women or in younger hospitalized populations, nor can
they be extrapolated to pediatric patients. Our findings may also
be influenced by the demographic composition of patients in our
cohort, the majority of whom were black…”

One of the
Study’s Authors Took A Research Grant From Gilead, Which Is
Developing A Hydroxychloroquine Competitor To Treat
Coronavirus

The study’s co-authors come from the University of Virginia or
the University of South Carolina. One of the authors, Jayakrishna
Ambati, is listed as the inventor on a University of Virginia
patent application “relating to COVID-19.” One of the study’s
co-authors, S. Scott Sutton, has taken research grant money from
Gilead Sciences, which is currently developing a Coronavirus drug
that is likely to be much more expensive than Hydroxychloroquine,
which costs less than one dollar per tablet.
Sutton’s curriculum vitae shows that on three occasions
dating back to 2012 he has studied the impact of therapies on
veterans with HIV/AIDS and then submitted that research to Gilead,
including two times as principal investigator for Gilead and
another company on projects funded for a total of $100,000.

Gilead spent
$5.72 million on lobbying in the year 2019. Gilead was
investigated by the Senate Finance Committee over the course of 18
months and accused in 2015 by Democrat Sen. Ron Wyden and
Republican Sen. Chuck Grassley of inflating the price of its
Hepatitis C drug Sovaldi.
A press release issued by the senators noted that “the
investigation found that the company pursued a marketing strategy
and final wholesale price of Sovaldi – $1,000 per pill, or
$84,000 for a single course of treatment – that it believed would
maximize revenue. Building on that price, Harvoni was later
introduced at $94,500. Fostering broad, affordable access was not a
key consideration in the process of setting the wholesale prices.
In the 18 months following Sovaldi’s approval, Medicare spent
nearly $8.2 billion before rebates on Sovaldi and Harvoni. Over
that same span, Medicare’s monthly spending on Hepatitis C
treatments increased more than six-fold. In 2014 alone, Medicare
and Medicaid combined to spend more than $5 billion on Sovaldi and
Harvoni before rebates.”

Democrat Senator Wyden stated: “Gilead pursued a calculated
scheme for pricing and marketing its Hepatitis C drug based on one
primary goal, maximizing revenue, regardless of the human
consequences…Gilead knew these prices would put treatment out of
the reach of millions and cause extraordinary problems for Medicare
and Medicaid, but still the company went ahead. If Gilead’s
approach to pricing is the future of how blockbuster drugs are
launched, it will cost billions and billions of dollars to treat
just a fraction of patients.”

Other Factors Cannot Be Ruled Out

The Associated Press was forced to report:

“About 28% who were given hydroxychloroquine plus usual care
died, versus 11% of those getting routine care alone. About 22% of
those getting the drug plus azithromycin died too, but the
difference between that group and usual care was not considered
large enough to rule out other factors that could have affected
survival. ”

Some Doctors Are Pairing Hydroxychloroquine With Zinc,
But The Study Does Not Mention Zinc

“What we’re finding clinically with our patients is that it
really only works in conjunction with Zinc,” stated Los Angeles
emergency room specialist Dr. Anthony Cardillo. “So the
hydroxychloroquine opens a zinc channel, zinc goes into the cell,
it then blocks the replication of the cellular machinery….Every
patient I’ve prescribed it to has been very very ill and within 8
to 12 hours they were basically symptom free.”

MEANWHILE… National Institutes of Health (NIH)
own a financial stake in the Bill Gates-funded Moderna Coronavirus
vaccine, raising big questions about the supposed impartiality of
the federal government’s policy decisions during the Coronavirus
outbreak. NIAID director Dr. Anthony Fauci, a financial ally of
Bill Gates whose institute is part of NIH, has been critical of
Hydroxychloroquine and the FBI even raided a health spa serving
intravenous vitamin C, which are competitors to a vaccine.

“We do have some particular stake in the intellectual
property” for the Moderna vaccine stated Francis Collins, the
director of NIH,
in a revelatory recent Economic Club panel discussion. “One
of the vaccines– the one that’s furthest along– what started,
actually, at the federal government in our own Vaccine Research
Center at NIH– then worked with a biotechnology company called
Moderna to get to where we are now, with very impressive Phase I
results and getting ready to go into a large-scale trial as early
as July. That one, of course, we do have some particular stake in
the intellectual property. Others, though, come from companies
who’ve invested their efforts into getting them to the point
where they might now be ready for a trial,”
Collins stated.

Newly published documents from Public Citizen have massive
implications. Public Citizen
states:

“The U.S. government may jointly own a potential coronavirus
vaccine. The National Institutes of Health (NIH) has played a
critical role in coronavirus research for years. Building off this
work, federal scientists have helped design and test mRNA-1273—a
vaccine candidate developed in partnership with Moderna.[2]
The federal government has filed multiple patents covering
mRNA-1273. In this report, we describe two patent applications that
list federal scientists as co-inventors.[3] If
the government successfully pursued its patent filings, the
resulting patents would likely confer significant rights. We also
review recently disclosed contracts between NIH and Moderna. The
agreements suggest that NIH has not transferred its rights, but
instead maintains a joint stake.”

Journalist Patrick Howley exposes the Coronavirus “Contact
Tracing” program in the first-ever episode of NATIONAL FILE
TV.Dr. Anthony
Fauci funded the Coronavirus bat research at the Wuhan Institute of
Virology, believed to be the source of the outbreak, then the
Political Class tried to suppress treatment as Fauci’s friend and
associate Bill Gates prepared mass vaccinations and the economy got
battered. And the whole episode was written out, planned, in
advance.

Here is the remarkable true story:

Why did the Bill and Melinda Gates Foundation fund
research at MIT on how to implant people’s vaccination
history under their skin? Why did Fauci meet with Bill Gates’
father, George Soros, and other globalist heavyweights all the way
back in 2001? Why did the Stephen King-created television series
The Dead Zone predict the Coronavirus outbreak — and a
Chloroquine cure for it — back in 2003?

Why did Dr. Anthony Fauci’s NIAID fund the Coronavirus bat
research at the Wuhan Institute of Virology, which President Trump
and Secretary of State Pompeo and others have identified as the
source of the worldwide outbreak?

WOW: Bill and Melinda Gates
Foundation provided funding for this research into storing patient
medical information within a person’s skin using a vaccine.

WAKE UP, AMERICA! https://t.co/JOEq4F59eE

— Patrick Howley (@HowleyReporter)
April 7, 2020

WOW: A high-level source just
sent me this photo, says that it shows Dr. FAUCI with George SOROS
and Bill Gates’ father among others. Source says it’s from 2001.
Fauci identified as man third from the left pic.twitter.com/l1NYyqHSAq

— Patrick Howley (@HowleyReporter)
April 6, 2020

HERE’S THE REAL STORY OF CONTACT TRACING

Some Republicans are voicing concern after Texas state health
officials granted a $295 million Coronavirus Contact Tracing deal
to MTX Group, a firm run by a man named Das Nobel, which faces
criticism for
previous work it did for the state of Kentucky. It turns out
the firm is a partner of Google, NATIONAL FILE has learned. MTX
Group got the contract without conservative Republican Lieutenant
Governor Dan Patrick being “in
the loop†to the decision process, and Patrick is just

one of numerous policymakers questioning the company’s deal
with the state, which authorizes MTX to serve as virus
investigators charting people’s contacts and relationships. MTX
has also partnered
during the Coronavirus outbreak with New York State and built
Contact Tracing technology employed in Georgia. So what’s really
going on here? It turns out MTX is bigtime partners
with Google:

I
reported: Department of Health and Human Services
(HHS) and Centers For Disease Control and Prevention (CDC) policy
confirms that “Contact Tracing†data may be sent to the World
Health Organization (WHO) and to law enforcement authorities “to
place someone under quarantine or isolation.†The Contact Tracing
records, stored at the CDC and elsewhere, can also be sent to the
Department of Justice, State Department, Department of Homeland
Security, congressional offices, and to various medical and legal
departments and contractors. Democrats are currently
seeking $100 billion in a bill that would authorize grants to
conduct contact tracing at people’s homes. Meanwhile, Americans
are fearing the political implications of contact tracing,
considering that Chelsea Clinton
is on the board of trustees of one official contact tracing
group that has accepted large sums of money from Bill Gates and
George Soros organizations.

HHS records show a System
of Records Notice (SORN 09-20-0171) in the Federal Register
marking the creation of the record system called “Quarantine- and
Traveler-Related Activities, Including Records for Contact Tracing
Investigation and Notification…†The records pertain
to “Individuals subject to quarantine or isolation
orders, ill travelers (i.e., passengers and crew), contacts of ill
travelers, and/or individuals exposed or suspected of being exposed
to serious communicable diseases.†The records
include: “Passenger and crew manifests from conveyances
carrying individuals subject to 42 CFR parts 70 and 71, case
reports, illness response forms, medical assessments, medical
records (including but not limited to clinical, hospital and
laboratory data and data from other relevant tests), name, address,
date of birth, and related information and documents collected for
the purpose of carrying out agency responsibilities under sections
311 and 361-368 of the Public Health Services Act.†The
records are being stored at: “Division of Global
Migration and Quarantine, National Center for the Preparedness,
Detection, and Control of Infectious Disease (NCPDCID),
Coordinating Center for Infectious Diseases (CCID), Centers for
Disease Control and Prevention, 1600 Clifton Road, NE., Building
16; MS E03, Atlanta, GA 30333. Records may occasionally be stored
at Quarantine Stations located at key ports of entry and at
contractor sites.â€

READ
THE HEALTH AND HUMAN SERVICES PRIVACY GUIDELINES HERE (emphasis
added):

“(1) Records may be disclosed to contractors
to handle program work duties, performing many of the same
functions as FTEs within DGMQ in situations where additional staff
is required. Contractors are required to maintain Privacy Act
safeguards with respect to such records.

(2) Records may be disclosed to state and local health
departments and other cooperating medical and public
health authorities and their counsel to more effectively deal with
outbreaks and other significant public health conditions.

(3) Personal information from this system may be disclosed as a
routine use to appropriate conveyance personnel, Federal agencies,
state and local health departments, Department of
State and embassy..

Read the Full Article